STAT

MAY 13, 2024

Today we learn whether AI might help hasten the development of n-of-1 therapies (hint: not yet), explore why the FDA hasn’t offered Orange Book guidance on drug-device combinations, and talk about CRISPR.   Sign up  to get our biotech newsletter in your inbox. Read the rest…

Drug Pricing 251

Drug Pricing Drug Development 251

STAT

JUNE 25, 2024

Today, STAT published our  annual list of the top books and podcasts  to check out this summer. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning.

Drug Pricing 241

Drug Pricing Drug Development 241

Definitive Healthcare

FEBRUARY 23, 2024

Resource Type E-Books & How-To Guides Blog How-To Guide Healthcare Insight Medical claims 101: What you need to know How to sell effectively to healthcare facilities and executives using the right… Hospital payor mix by state Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToS

Drug Pricing 52

Drug Pricing Hospitals Drug Development 52

European Pharmaceutical Review

OCTOBER 19, 2022

1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Biopharmaceutical Research & Development: The Process Behind New Medicines. CN202010111235.3A.

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96